Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- First Switch OTC Drug for Urinary Frequency for Women to Be Approved
September 17, 2007
- JA-Zenkouren Considers Collective Bargaining on Drug Prices
September 17, 2007
- Kyowa Hakko Launches Line of L-Citrulline Health Foods
September 17, 2007
- Blopress Maintains Top Position in 2nd Qtr: IMS Japan
September 17, 2007
- Hearings Completed for New Vision for Medical Devices Industry
September 17, 2007
- TOPICS／Seminar Aimed at Employment of Female MRs Attracts 300 Participants
September 17, 2007
- NEW PRODUCST
September 17, 2007
- Taiyo's Tablet Production Capacity Up to 8.5 Bil. Per Year
September 17, 2007
- JPA Leaders Exchange Opinions with New Health Minister
September 17, 2007
- BUSINESS NEWS IN BRIEF
September 17, 2007
- JPA Would Like to Expand the Role of Pharmacists
September 17, 2007
- No Reduction in Technical Fees Considered: New Health Minister
September 17, 2007
- Med. Fee Curtailment Policy Caused Collapse of Med. Insurance System: 3 Social Insurance Unions
September 17, 2007
- Korosho to Shift Priority from Treatment of ADRs to Prevention
September 17, 2007
- TOPICS／JADEC, sanofi-aventis Hold HbA1c Awareness Promotion Campaign
September 17, 2007
- Use e-Details to Enhance QOV: Mr Takuma of CareNet
September 17, 2007
- Japan's First New-Type Influenza Vaccines Recommended for Approval
September 17, 2007
- SURVEY／Antirheumatic Drug Market Grew by 49% in 2006: Fuji Keizai Databook
September 17, 2007
- GENERICS NEWS IN BRIEF
September 17, 2007
- EFPIA Appreciates 20% Increase in Budget Request for Innovation
September 17, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…